Improved Survival in a Cohort of Trial Participants with Metastatic Castration-resistant Prostate Cancer Demonstrates the Need for Updated Prognostic Nomograms-Reference-Cited by-同舟云学术

Improved Survival in a Cohort of Trial Participants with Metastatic Castration-resistant Prostate Cancer Demonstrates the Need for Updated Prognostic Nomograms

Published:2013-08 Issue:2 Volume:64 Page:300-306
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Omlin Aurelius,Pezaro Carmel,Mukherji Deborah,Mulick Cassidy Amy,Sandhu Shahneen,Bianchini Diletta,Olmos David,Ferraldeschi Roberta,Maier Gal,Thompson Emilda,Parker Chris,Attard Gerhardt,de Bono Johann

Publisher

Elsevier BV

Subject

Urology

Reference32 articles.

1. Cancer statistics, 2010;Jemal;CA Cancer J Clin,2010

2. Prostate Cancer Survival Statistics. Cancer Research UK Web site. www.info.cancerresearchuk.org/cancerstats/types/prostate/survival/prostate-cancer-survival-statistics.

3. Prognostic model for predicting survival in men with hormone-refractory metastatic prostate cancer;Halabi;J Clin Oncol,2003

4. Nomogram for overall survival of patients with progressive metastatic prostate cancer after castration;Smaletz;J Clin Oncol,2002

5. A contemporary prognostic nomogram for men with hormone-refractory metastatic prostate cancer: a TAX327 study analysis;Armstrong;Clin Cancer Res,2007

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of different visceral metastatic sites on survival in metastatic prostate cancer patients;PLOS ONE;2024-09-06

2. Combination of Blood Adiponectin and Leptin Levels Is a Predictor of Biochemical Recurrence in Prostate Cancer Invading the Surrounding Adipose Tissue;International Journal of Molecular Sciences;2024-08-17

3. Survival by first‐line therapy and prognostic group among men with metastatic castration‐resistant prostate cancer;Cancer Medicine;2024-06

4. Integrative analysis of transcriptomic and metabolomic profiles reveals enhanced arginine metabolism in androgen-independent prostate cancer cells;BMC Cancer;2023-12-16

5. Natural killer cell activity in metastatic castration resistant prostate cancer patients treated with enzalutamide;Scientific Reports;2023-10-10